Epidemiology and molecular biology of Barrett esophagus

Seminars in Thoracic and Cardiovascular Surgery

Volumn 17, Issue 4, 2005, Pages 284-291

  Casson, Alan G ^a   Williams, Lara ^a   Guernsey, Duane L ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Barrett esophagus; Epidemiology; Molecular biology

Indexed keywords

BIOLOGICAL MARKER; CYCLIN D1; PROTEIN P16INK4A; PROTEIN P53;

AGE; ANEUPLOIDY; ARTICLE; BARRETT ESOPHAGUS; BODY MASS; CANCER INCIDENCE; CANCER RISK; CHRONIC DISEASE; DEMOGRAPHY; DISEASE COURSE; DISEASE SEVERITY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS INJURY; ESOPHAGUS MUCOSA; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DYSPLASIA; GENDER; HETEROZYGOSITY LOSS; HUMAN; INTESTINE METAPLASIA; LIFESTYLE; MOLECULAR BIOLOGY; PATHOGENESIS; PREDICTION; PREVALENCE; PROTEIN EXPRESSION; RISK FACTOR; SYMPTOM;

EID: 31144433105     PISSN: 10430679     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semtcvs.2005.09.005     Document Type: Article

References (112)

1. W.J. Blot J.K. McLaughlin The changing epidemiology of esophageal cancer Semin Oncol 26 1999 2-8
2. A.A.M. Botterweck L.J. Schouten A. Volovics. et al. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries Int J Epidemiol 29 2000 645-654
3. J. Powell C.C. McConkey E.W. Gillison. et al. Continuing rising trend in oesophageal adenocarcinoma Int J Cancer 102 2002 422-427
4. S.T. Mayne S.A. Navarro Diet, obesity and reflux in the etiology of adenocarcinomas of the esophagus and gastric cardia in humans J Nutr 132 2002 3467S-3470S
5. D. Forman Oesophago-gastric adenocarcinoma - an epidemiological perspective Aliment Pharmacol Ther 20 2004 55-60
6. J. Lagergren Adenocarcinoma of oesophagus: What exactly is the size of the problem and who is at risk? Gut 54 2005 1-5
7. A. Wong R.C. Fitzgerald Epidemiologic risk factors for Barrett's esophagus and associated adenocarcinoma Clin Gastroenterol Hepatol 3 2005 1-10
8. R.J. Kuczmarski K.M. Flegal S.M. Campbell. et al. Increasing prevalence of overweight among US adults. The national health and nutrition examination surveys,1960-1991 JAMA 272 1994 205-211
9. J.C. Seidell K.M. Flegal Assessing obesity: Classification and epidemiology Br Med Bull 53 1997 238-252
10. E.E. Calle C. Rodriguez K. Walker-Thurmond. et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults N Engl J Med 348 2003 1625-1638
11. L.M. Brown C.A. Swanson G. Gridley. et al. Adenocarcinoma of the esophagus role of obesity and diet J Natl Cancer Inst 87 1995 104-109
12. T.L. Vaughan S. Davis A. Kristal. et al. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia adenocarcinoma versus squamous cell carcinoma Cancer Epidemiol Biomark Prev 4 1995 85-92
13. W.-H. Chow W.J. Blot T.L. Vaughan. et al. Body mass index and risk for adenocarcinoma of the esophagus and gastric cardia J Natl Cancer Inst 90 1998 150-155
14. J. Lagergren R. Bergstrom O. Nyren Association between body mass and adenocarcinoma of the esophagus and cardia Ann Intern Med 130 1999 883-890
15. A.H. Wu P. Wan L. Bernstein A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States) Cancer Causes Control 12 2001 721-732
16. L.S. Engel W.-H. Chow T.L. Vaughan. et al. Population attributable risks of esophageal and gastric cancers J Natl Cancer Inst 95 2003 1404-1413
17. W.-H. Chow W.D. Finkle J.K. McLaughlin. et al. The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia JAMA 274 1995 474-477
18. D.C. Farrow T.L. Vaughn C. Sweeney. et al. Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer Cancer Causes Control 11 2000 231-238
19. J. Lagergren R. Bergstrom A. Lindgren. et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma N Engl J Med 340 1999 825-831
20. Z.-F. Zhang R.C. Kurtz G.-P. Yu. et al. Adenocarcinomas of the esophagus and gastric cardia the role of diet Nutr Cancer 10 2001 1055-1062
21. P. Terry J. Lagergren W. Ye. et al. Antioxidants and cancers of the esophagus and gastric cardia Int J Cancer 87 2000 750-754
22. S.T. Mayne H.A. Risch R. Dubrow. et al. Nutrient intake and risk of subtypes of esophageal and gastric cancer Cancer Epidemiol Biomark Prev 10 2001 1055-1062
23. Z.-F. Zhang R.C. Kurtz M. Sun. et al. Adenocarcinomas of the esophagus and gastric cardia medical conditions, tobacco, alcohol and socioeconomic factors Cancer Epidemiol Biomark Prev 5 1996 761-768
24. M.D. Gammon J.B. Schoenberg H. Ahsan. et al. Tobacco, alcohol and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia J Natl Cancer Inst 89 1997 1277-1284
25. P.C. Enzinger R.J. Mayer Esophageal cancer N Engl J Med 349 2003 2241-2252
26. S.J. Specher Clinical practice. Barrett's esophagus N Engl J Med 346 2002 836-842
27. J.A. Jankowski N.A. Wright S.J. Meltzer. et al. Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus Am J Pathol 154 1999 965-973
28. N. Shaheen D.F. Ransohoff Gastroesophageal reflux, Barrett's esophagus and esophageal cancer JAMA 287 2002 1972-1981
29. A.G. Casson Role of molecular biology in the follow-up of patients who have Barrett's esophagus Chest Surg Clin N Am 12 2002 93-111
30. B.J. Reid P.L. Blount P.S. Rabinovitch Biomarkers in Barrett's esophagus Gastrointest Clin N Am 13 2003 369-397
31. D.T. McManus A. Olaru S.J. Meltzer Biomarkers of esophageal adenocarcinoma and Barrett's esophagus Cancer Res 64 2004 1561-1569
32. R.E. Sampliner Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus Am J Gastroenterol 93 1998 1028-1032
33. S.J. Spechler Columnar-lined esophagus. Definitions Chest Surg Clin N Am 12 2002 1-13
34. R.C. Haggitt Barrett's esophagus, dysplasia, and adenocarcinoma Hum Pathol 25 1994 983-993
35. D.A. Antonelli H.H. Wang Morphology of Barrett's esophagus and Barrett's-associated dysplasia and adenocarcinoma Gastroenterol Clin N Am 26 1997 495-506
36. S. Oberg T.R. DeMeester J.H. Peters. et al. The extent of Barrett's esophagus depends on the status of the lower esophageal sphincter and the degree of acid exposure J Thorac Cardiovasc Surg 117 1999 572-580
37. S.R. DeMeester T.R. DeMeester Columnar mucosa and intestinal metaplasia of the esophagus. Fifty years of controversy Ann Surg 3 2000 303-321
38. S.J. Spechler J.M. Zeroogian D.A. Antonioli. et al. Prevalence of metaplasia at the gastro-oesophageal junction Lancet 344 1994 1533-1536
39. S.J. Spechler Short and ultrashort Barrett's esophagus: What does it mean? Semin Gastrointest Dis 8 1997 59-67
40. G.W.B. Clark T.C. Smyrk P. Burdiles. et al. Is Barrett's metaplasia the source of adenocarcinomas of the cardia? Arch Surg 129 1994 609-614
41. A. Ruol A. Parenti G. Zaninotto. et al. Intestinal metaplasia is the probable common precursor of adenocarcinoma in Barrett esophagus and adenocarcinoma of the gastric cardia Cancer 88 2000 2520-2528
42. A.H. Ormsby M.F. Vaezi J.E. Richter. et al. Cytokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett's esophagus Gastroenterology 119 2000 683-690
43. J.E. McArdle K.J. Lewin G. Randall. et al. Distribution of dysplasias and early invasive carcinoma in Barrett's esophagus Hum Pathol 23 1992 479-482
44. N.S. Buttar K.K. Wang T.J. Sebo. et al. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma Gastroenterology 120 2001 1630-1639
45. T.G. Schnell S.J. Sontag G. Chejfec. et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia Gastroenterology 120 2001 1607-1619
46. L.A. Anderson L.J. Murray S.J. Murphy. et al. Mortality in Barrett's oesophagus results from a population based study Gut 52 2003 1081-1084
47. J.R. Siewert H.J. Stein Classification of adenocarcinoma of the oesophagogastric junction Br J Surg 85 1998 1457-1459
48. A.G. Casson T. Mukhopadhyay K.R. Cleary. et al. p53 gene mutations in Barrett's epithelium and esophageal cancer Cancer Res 51 1991 4495-4499
49. M. Pera Trends in incidence and prevalence of specialized intestinal metaplasia, Barrett's esophagus, and adenocarcinoma of the gastroesophageal junction World J Surg 27 2003 999-1008
50. Grupo Operativo per lo Studio delle Precancerosi dell'Esofago (GOSPE) Barrett's esophagus epidemiological and clinical results of a multicentric survey Int J Cancer 48 1991 364-368
51. A.J. Cameron Epidemiology of columnar-lined esophagus and adenocarcinoma Gastroenterology Clin N Am 26 1997 487-494
52. A.J. Cameron C.T. Lomboy Barrett's esophagus: Age, prevalence and extent of columnar epithelium Gastroenterology 103 1992 1241-1245
53. L. Bonelli Barrett's esophagus: Results of a multicentric survey Endoscopy 103 1993 652-654
54. M.H. Johnston A.H. Hammond W. Laskin. et al. The prevalence and clinical characteristics of short segments of specialized intestinal metaplasia in the distal esophagus on routine endoscopy Am J Gastroenterol 91 1996 1507-1511
55. A.J. Cameron A.R. Zinsmeister D.J. Ballard. et al. Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based and autopsy findings Gastroenterology 99 1990 918-922
56. M. Conio A.J. Cameron Y. Romero. et al. Secular trends in the epidemiology and outcomes of Barrett's oesophagus in Olmsted County, Minnesota Gut 48 2001 304-309
57. A.T. Prach Increasing incidence of Barrett's esophagus: Education, enthusiasm, or epidemiology? Lancet 350 1997 933
58. C.P.J. Caygill P.I. Reed B.J. Johnston. et al. A single centre's 20 year experience of columnar-lined (Barrett's) oesophagus diagnosis Eur J Gastroenterol Hepatol 11 1999 1355-1358
59. P. Sharma T.G. Morales R.E. Sampliner Short segment Barrett's esophagus: the need for standardization and the definition of endoscopic criteria Am J Gastroenterol 93 1998 1033-1036
60. W.K. Hirota T.M. Loughney D.J. Lazas. et al. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction prevalence and clinical data Gastroenterology 116 1999 277-285
61. P. Sharma P. Weston T. Morales. et al. Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and on the gastric cardia Gut 46 2000 9
62. P. Sharma T. Morales A. Bhattacharia. et al. Dysplasia in short segment Barrett's esophagus: A prospective 3-year follow-up Am J Gastroenterol 92 1997 2012-2016
63. G. Champion J.E. Richter M.F. Vaezi. et al. Duodenogastroesophageal reflux: Relationship to pH and importance in Barrett's esophagus Gastroenterology 107 1994 747-754
64. S.R. Goldstein G. Yang S.K. Curtis. et al. Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen Carcinogenesis 18 1997 2265-2270
65. M.F. Vaezi J.E. Richter Bile reflux in columnar-lined esophagus Gastroenterol Clin North Am 26 1997 565-582
66. B.J. Reid P.L. Blount C.E. Rubin. et al. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort Gastroenterology 102 1992 1212-1219
67. M.R. Gray P.A. Hall J. Nash. et al. Epithelial proliferation in Barrett's esophagus by proliferating cell nuclear antigen immunolocalization Gastroenterology 103 1992 1769-1776
68. P. Gillen M. McDermott D. Grehan. et al. Proliferating cell nuclear antigen in the assessment of Barrett's mucosa Br J Surg 81 1994 1766-1768
69. M.K. Hong W.B. Laskin B.E. Herman. et al. Expansion of the Ki-67 proliferative compartment correlates with degree of dysplasia in Barrett's esophagus Cancer 75 1995 423-429
70. N. Chalasani J.M. Wo J.G. Hunter. et al. Significance of intestinal metaplasia in different areas of the esophagus including the esophagogastric junction Dig Dis Sci 42 1997 603-607
71. J.E. Richter Intestinal metaplasia and the squamocolumnar junction: What does it all mean? Gut 42 1998 604-605
72. Y.Y. Chen D.A. Antonioli S.J. Spechler. et al. Gastroesophageal reflux disease versus Helicobacter pylori infection as the cause of gastric carditis Mod Pathol 11 1998 950-956
73. M.F. Vaezi G.W. Falk R.M. Peek. et al. CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus Am J Gastroenterol 95 2000 2206-2211
74. N. Trudgill Familial factors in the etiology of gastroesophageal reflux disease, Barrett's esophagus, and esophageal adenocarcinoma Chest Surg Clin N Am 12 2002 15-24
75. S. Sartori I. Nielsen M. Indelli. et al. Barrett esophagus after chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil (CMF): An iatrogenic injury? Ann Int Med 114 1991 210-211
76. M. McKinley P. Sherlock Barrett's esophagus with adenocarcinoma in scleroderma Am J Gastroenterol 79 1984 438-439
77. S.J. Spechler E.M. Schimmell J.W. Dalton Barrett's esophagus complicating lye ingestion with sparing of the distal esophagus Gastroenterology 81 1981 580-583
78. W. Meyer F. Vollmar W. Bar Barrett's esophagus following total gastrectomy Endoscopy 2 1979 121-126
79. P. Kortan R.E. Warren J. Gardner. et al. Barrett's esophagus in a patient with surgically resected achalasia J Clin Gastroenterol 3 1981 357-360
80. D.F. Hayes R.C. Bast C.E. Desch. et al. Tumor marker utility grading system: A framework to evaluate clinical utility of tumor markers J Natl Cancer Inst 88 1996 1456-1466
81. M.S. Pepe R. Etziomi Z. Feng. et al. Phases of biomarker development for early detection of cancer J Natl Cancer Inst 93 2001 1054-1061
82. M.B. Menke-Pluymers A.H. Mulder W.C. Hop. et al. The Rotterdam Oesophageal Tumor Study Group Dysplasia and aneuploidy as markers of malignant degeneration in Barrett's esophagus Gut 35 1994 1348-1351
83. P.C. Galipeau D.S. Cowan C.A. Sanchez. et al. 17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus Proc Natl Acad Sci USA 93 1996 7081-7084
84. E.A. Montgomery D.P. Hartmann N.J. Carr. et al. Barrett esophagus with dysplasia. Flow cytometric DNA analysis of routine, paraffin-embedded mucosal biopsies Am J Clin Pathol 106 1996 298-304
85. L. Tedori W. Gohde M. Persiani. et al. DNA/protein flow cytometry as a predictive marker of malignancy in dysplasia-free Barrett's esophagus: thirteen-year follow-up study of a cohort of patients Cytometry 34 1998 257-263
86. B.J. Reid P.L. Blount Z. Feng. et al. Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia Am J Gastroenterol 95 2000 3089-3096
87. B.J. Reid D.S. Levine G. Longton. et al. Predictors of progression to cancer in Barrett's esophagus: Baseline histology and flow cytometry identify low- and high-risk patient subsets Am J Gastroenterol 95 2000 1669-1676
88. B.J. Reid L.J. Prevo P.C. Galipeay. et al. Predictors of progression in Barrett's esophagus II: Baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression Am J Gastroenterol 96 2001 2839-2848
89. P.S. Rabinovitch G. Longton P.L. Blount. et al. Predictors of progression in Barrett's esophagus III: Baseline flow cytometric variables Am J Gastroenterol 96 2001 3071-3083
90. W.H. Raskind T.H. Norwood D.S. Levine. et al. Persistent clonal areas and clonal expansion in Barrett's esophagus Cancer Res 52 1992 2946-2950
91. M.T. Barrett C.A. Sanchez L.J. Prevo. et al. Evolution of neoplastic cell lineages in Barrett oesophagus Nat Genet 22 1999 106-109
92. T. Nakamura H. Nekarda A.H. Holscher. et al. Prognostic value of DNA ploidy and c-erb-B2 oncoprotein expression in adenocarcinoma of Barrett's esophagus Cancer 73 1994 1785-1794
93. M. Sarbia G. Molsberger R. Willers. et al. The prognostic significance of DNA ploidy in adenocarcinomas of the esophagogastric junction J Cancer Res Clin Oncol 122 1996 186-188
94. C.M. Gleeson J.M. Sloan D.T. McManus. et al. Comparison of p53 and DNA content abnormalities in adenocarcinoma of the esophagus and gastric cardia Br J Cancer 77 1998 277-286
95. A. Chanvitan P. Puttawibul A.G. Casson Flow cytometry in squamous cell esophageal cancer and precancerous lesions Dis Esophagus 10 1997 206-210
96. C. Prives P.A. Hall The p53 pathway J Pathol 187 1999 112-116
97. S. Sengupta C.C. Harris p53: Traffic cop at the crossroads of DNA repair and recombination Nat Rev 6 2005 44-55
98. C.C. Harris Structure and function of the p53 tumor suppressor gene clues for rational cancer therapeutic strategies J Natl Cancer Inst 88 1996 1442-1445
99. R.R. Wallace-Brodeur S.W. Lowe Clinical implications of p53 mutations Cell Mol Life Sci 54 1999 64-75
100. A.G. Casson T. Mukhopadhyay K.R. Cleary. et al. p53 gene mutations in Barrett's epithelium and esophageal cancer Cancer Res 51 1991 4495-4499
101. P.M. Schneider A.G. Casson B. Levin. et al. Mutations of p53 in Barrett's esophagus and Barrett's cancer: A prospective study of 98 cases J Thorac Cardiovasc Surg 111 1996 323-333
102. A.G. Casson S.C. Evans A. Gillis. et al. Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinoma: Results of a 10-year prospective study J Thorac Cardiovasc Surg 125 2003 1121-1131
103. A.W. Murray Recycling the cell cycle: Cyclins revisited Cell 116 2004 221-234
104. N. Arber C. Lightdale H. Rotterdam. et al. Increased expression of the cyclin D1 gene in Barrett's esophagus Cancer Epidemiol Biomark Prev 5 1996 457-459
105. K. Bani-Hani I.G. Martin L.J. Hardie. et al. Prospective study of cyclin D1 overexpression in Barrett's esophagus: Association with increased risk of adenocarcinoma J Natl Cancer Inst 92 2000 1316-1321
106. D.C. Betticher N. Thatcher H.J. Altermatt. et al. Alternate splicing produces a novel cyclin D1 transcript Oncogene 11 1995 1005-1011
107. D.A. Solomon Y. Wang S.R. Fox. et al. Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation J Biol Chem 278 2003 30339-30347
108. F. Lu A.B. Gladden J.A. Diehl An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene Cancer Res 63 2003 7056-7061
109. A.G. Casson Z. Zheng S.C. Evans. et al. Cyclin D1 polymorphism G870A and risk for esophageal adenocarcinoma Cancer 104 2005 730-739
110. INK4a genes in human esophageal squamous cell carcinoma Clin Cancer Res 5 1999 2704-2713
111. C.C. Maley P.C. Galipeau X. Li. et al. Selectively advantageous mutations and hitchhikers in neoplasma p16 lesions are selected in Barrett's esophagus Cancer Res 64 2004 3414-3427
112. L.J. Hardie S.J. Darnton Y.L. Wallis. et al. p16 expression in Barrett esophagus and esophageal adenocarcinoma: Association with genetic and epigenetic alterations Cancer Lett 217 2005 221-230